Cardiac REperfusion With Intralipid® at Reperfusion

NCT02807727 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Reperfusion Injury

Interventions

DRUG: Intralipid 20%
DRUG: Modified Ringers Lactate

Sponsor

Nkanyiso Hadebe